PrediSurge

📍 St-Étienne, France🗓 Founded 2017👥 29 employees💰 Last funded Jan 2024

PrediSurge develops a precision medicine platform to assist physicians in better planning their endovascular interventions. Based on pre-operative imaging, our technology enables creation of patient-specific digital twins: numerical models simulating arteries and valves biomechanical behavior. In a clinical context, these digital models can be used to numerically investigate different device implantation approaches and to determine the best strategy for a specific patient. In an industrial context, use of digital twins boosts innovative product development by early de-risking of avant-garde technologies, compressing design iteration period and early prediction of in-vivo performances. It’s a cost-effective solution to test in-silico several medical device designs at every stage of the development process. Our end goal is to make endovascular procedures ever safer for the patient, by providing physicians and medtech companies with numerical tools to improve procedures planning and medical devices designs.

Total investors

Early stage

Mid stage

Late stage

2017

Founded